|
CENPH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.736700E-03 |
| Normal-vs-Stage3 |
1.31469999997691E-07 |
| Normal-vs-Stage4 |
1.277020E-03 |
| Stage1-vs-Stage2 |
7.448400E-01 |
| Stage1-vs-Stage3 |
3.519500E-02 |
| Stage1-vs-Stage4 |
7.768000E-02 |
| Stage2-vs-Stage3 |
2.883000E-01 |
| Stage2-vs-Stage4 |
1.980810E-01 |
| Stage3-vs-Stage4 |
5.100000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
7.01694258253838E-12 |
| Normal-vs-Asian |
7.059500E-03 |
| Caucasian-vs-AfricanAmerican |
3.557400E-01 |
| Caucasian-vs-Asian |
4.466800E-01 |
| AfricanAmerican-vs-Asian |
2.330600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
6.99440505513849E-15 |
| Male-vs-Female |
1.036750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.02470004598376E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.11022302462516E-14 |
| Normal-vs-Extreme_Obese |
4.401300E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.692200E-01 |
| Normal_Weight-vs-Obese |
7.051400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.670200E-02 |
| Extreme_Weight-vs-Obese |
3.328400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.257630E-01 |
| Obese-vs-Extreme_Obese |
5.956500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.66730000000271E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
8.364300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.044100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.928040E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.867800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.238600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.898600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.916800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.00120000068316E-08 |
| Normal-VS-KIRP CIMP |
3.245500E-04 |
| Normal-VS-Unclassified PRCC |
1.40940000004086E-07 |
| Type1 PRCC-VS-Type2 PRCC |
4.444000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.397720E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.739200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.55180000005473E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
9.645800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.078860E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.77059999784524E-08 |
| Normal-vs-N1 |
1.64076999999985E-05 |
| Normal-vs-N2 |
2.997900E-02 |
| N0-vs-N1 |
2.612000E-02 |
| N0-vs-N2 |
1.847800E-02 |
| N1-vs-N2 |
5.183800E-01 |
|
|
